Excellent reading Orioles.
Thanks for posting it.
Great to see us up there on the Leader's Board.
So we have got the Breakthrough Therapy Status from the FDA.
The only other one who holds that status at the moment being Intercept.
Type of drug : anti-LPS antibodies and adjuvants
Clinical trials advancement : Initiating Phase 3
The drug got the Breakthrough Therapy Status granted by the FDA
Estimated time to market : 62 months.
I would assume that if we were given the Fast Track Status by the FDA during Phase 3, that would shorten the time to market as well as reducing costs considerably.
Add to My Watchlist
What is My Watchlist?
